ArticleIJID regions2026
Antimicrobial resistance in Palestine: Emerging hotspots and trends from a 4-year hospital-based study.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antibiotic resistance in E.coli isolated from mint in local markets in Hebron, Palestine.BMC microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: We aimed to conduct a 4-year retrospective analysis of antimicrobial resistance (AMR) trends and infection hotspots within a major referral hospital in West Bank. Methods: A total of 18,802 bacterial isolates from 15,147 patients from the Palestine Medical Complex were assessed from January 2020 to December 2023. Data were analyzed to yield organism prevalence, trends of resistance, and ward-level infection burdens. Results: Resistant isolates increased from 31.9% in 2020 to 37.7% in 2023, driven primarily by extended-spectrum β-lactamase-producing Conclusion: The escalating AMR threat signifies the importance of surveillance and warrants an urgent, targeted AMR intervention. Implementation of ward-specific antimicrobial stewardship, demographic-targeted infection control, and regional data-sharing frameworks are critical to mitigating the spread of AMR in conflict-affected and fragile health systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.